Literature DB >> 16884851

Deltamethrin-impregnated collars for the control of canine leishmaniasis: evaluation of the protective effect and influence on the clinical outcome of Leishmania infection in kennelled stray dogs.

V Foglia Manzillo1, G Oliva, A Pagano, L Manna, M Maroli, L Gradoni.   

Abstract

A 2-year field study on kennelled stray dogs living in a highly endemic area of leishmaniasis was designed to evaluate whether deltamethrin-impregnated collars (Scalibor) Protector Band) could confer protection against leishmaniasis in this peculiar setting, and to assess differences in clinical outcomes between collared and uncollared dogs. A cohort of 120 clinically healthy and Leishmania-seronegative dogs was enrolled, 50% of which were collared before the 2003 transmission season, and then re-collared before the subsequent season. Collared and uncollared animals were allowed to live with infected dogs in same groups within the kennel. Follow-up included serological (IFAT) assessment twice a year with parasitological Leishmania confirmation, and clinical evaluation performed every 3 months on seroconverted dogs from both groups. Collar losses during the two seasons were high (35%). About 50% of enrolled dogs were lost at follow-up because of death or they were moved to other locations. After the 2003 season, cross-sectional serological examinations tested positive in 5 out of 44 collared animals (11.4%) and in 14 out of 34 controls (41.2%), with 72.3% estimated protection (P<0.005). After the 2004 season, 7/31 seronegative collared dogs seroconverted (22.6%) compared with 7/17 seronegative controls (41.2%), with 45.1% protection (P=0.15). At the end of the study, the cumulative rate of protection was 50.8% (P=0.005). At the clinical evaluation of 21 seroconverted dogs from both groups, canine leishmaniasis signs were significantly more frequent (90% versus 36%, P=0.017) and rapidly progressive in uncollared than in collared dogs. Reasons for such partial clinical protection in collared dogs may be found in the vector anti-feeding effect of protector bands, resulting in a lower number of infectious bites and, probably, in the reduction of antigenic stimuli necessary to shift toward a non-protective immune response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884851     DOI: 10.1016/j.vetpar.2006.06.029

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  27 in total

1.  Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.

Authors:  Joelma Trigo; Melissa Abbehusen; Eduardo M Netto; Maria Nakatani; Geraldo Pedral-Sampaio; Robson Silva de Jesus; Yasuyuki Goto; Jeffrey Guderian; Randall F Howard; Steven G Reed
Journal:  Vaccine       Date:  2010-03-04       Impact factor: 3.641

2.  Canine leishmaniasis in North America: emerging or newly recognized?

Authors:  Christine A Petersen; Stephen C Barr
Journal:  Vet Clin North Am Small Anim Pract       Date:  2009-11       Impact factor: 2.093

Review 3.  Leishmaniasis, an emerging disease found in companion animals in the United States.

Authors:  Christine A Petersen
Journal:  Top Companion Anim Med       Date:  2009-11

Review 4.  Neglected and endemic zoonoses.

Authors:  Ian Maudlin; Mark Charles Eisler; Susan Christina Welburn
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-09-27       Impact factor: 6.237

5.  LeishVet guidelines for the practical management of canine leishmaniosis.

Authors:  Laia Solano-Gallego; Guadalupe Miró; Alek Koutinas; Luis Cardoso; Maria Grazia Pennisi; Luis Ferrer; Patrick Bourdeau; Gaetano Oliva; Gad Baneth
Journal:  Parasit Vectors       Date:  2011-05-20       Impact factor: 3.876

6.  Methods of Control of the Leishmania infantum Dog Reservoir: State of the Art.

Authors:  Michele Podaliri Vulpiani; Luigi Iannetti; Daniela Paganico; Filomena Iannino; Nicola Ferri
Journal:  Vet Med Int       Date:  2011-07-07

7.  Use of a LiESP/QA-21 vaccine (CaniLeish) stimulates an appropriate Th1-dominated cell-mediated immune response in dogs.

Authors:  Javier Moreno; Ioannis Vouldoukis; Virginie Martin; David McGahie; Anne-Marie Cuisinier; Sylvie Gueguen
Journal:  PLoS Negl Trop Dis       Date:  2012-06-19

8.  Vaccine effectiveness and use of collar impregnated with insecticide for reducing incidence of Leishmania infection in dogs in an endemic region for visceral leishmaniasis, in Brazil.

Authors:  E G Lopes; A P Sevá; F Ferreira; C M Nunes; L B Keid; R M Hiramoto; H L Ferreira; T M F S Oliveira; F G Ovallos; E A B Galati; T J Villegas; D V Bortoletto; S Y O B Valadas; R M Soares
Journal:  Epidemiol Infect       Date:  2018-01-18       Impact factor: 4.434

9.  Prevention of canine leishmaniosis in a hyper-endemic area using a combination of 10% imidacloprid/4.5% flumethrin.

Authors:  Domenico Otranto; Filipe Dantas-Torres; Donato de Caprariis; Giancarlo Di Paola; Viviana D Tarallo; Maria S Latrofa; Riccardo P Lia; Giada Annoscia; Edward B Breitshwerdt; Cinzia Cantacessi; Gioia Capelli; Dorothee Stanneck
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

10.  Laboratory evidence that dinotefuran, pyriproxyfen and permethrin combination abrogates Leishmania infantum transmissibility by sick dogs.

Authors:  G Bongiorno; A Bosco; R Bianchi; L Rinaldi; V Foglia Manzillo; M Gizzarelli; M P Maurelli; D Giaquinto; N El Houda Ben Fayala; M Varloud; A Crippa; G Oliva; L Gradoni; G Cringoli
Journal:  Med Vet Entomol       Date:  2021-11-01       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.